EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin acts in the gut and induces gut-liver crosstalk

Natália Tobar iD, Guilherme Z Rocha iD, Andrey Santos, Dioze Guadagnini, Heloísa B Assalin iD, Juliana A Camargo iD, Any E S S Gonçalves, Flavia R Pallis, Alexandre G Oliveira iD, Silvana A Rocco iD, Raphael M Neto iD, Irene Layane de Sousa iD und 19 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2211933120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Natália Tobar und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, 13083-887 Brazil. Hauptthemen laut MEDLINE: Glucose, Liver, Metformin, Gastrointestinal Tract. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: INCT Obesidade e Diabetes-CNPq, INCT Obesidade e diabetes - Fapesp, Capes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin is the most prescribed drug for DM2, but its site and mechanism of action are still not well established. Here, we investigated the effects of metformin on basolateral intestinal glucose uptake (BIGU), and its consequences on hepatic glucose production (HGP). In diabetic patients and mice, the primary site of metformin action was the gut, increasing BIGU, evaluated through PET-CT. In mice and CaCo2 cells, this increase in BIGU resulted from an increase in GLUT1 and GLUT2, secondary to ATF4 and AMPK. In hyperglycemia, metformin increased the lactate (reducing pH and bicarbonate in portal vein) and acetate production in the gut, modulating liver pyruvate carboxylase, MPC1/2, and FBP1, establishing a gut-liver crosstalk that reduces HGP. In normoglycemia, metformin-induced increases in BIGU is accompanied by hypoglycemia in the portal vein, generating a counter-regulatory mechanism that avoids reductions or even increases HGP. In summary, metformin increases BIGU and through gut-liver crosstalk influences HGP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucoseLiverMetforminGastrointestinal TractAnimalsHumansMiceCaco-2 CellsDiabetes Mellitus, Type 2Hypoglycemic AgentsPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

DiabetesMetforminglucose metabolismgut-liver crosstalk

Substanzen

GlucoseHypoglycemic AgentsMetformin

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, 13083-887 Brazil.
  • Department of Physical Education, São Paulo State University, Rio Claro, 13506-900 Brazil.
  • Brazilian Biosciences National Laboratory and Brazilian Center for Research in Energy and Materials, Campinas, 13083-100 Brazil.
  • Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, 13083-970 Brazil.
  • Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas, Campinas, São Paulo, 13083-970.
  • Department of Structural and Functional Biology, University of Campinas, Campinas, 13083-865 Brazil.

ORCID-Profile: Natália Tobar, Guilherme Z Rocha, Heloísa B Assalin, Juliana A Camargo, Alexandre G Oliveira, Silvana A Rocco, Raphael M Neto, Irene Layane de Sousa, Marcos R Alborghetti, Maurício L Sforça, Carla R O Carvalho, Patricia O Prada, Rui Curi, Marcelo A Mori, Celso D Ramos

Förderung

  • INCT Obesidade e Diabetes-CNPq
  • INCT Obesidade e diabetes - Fapesp
  • Capes

Zitieren

APA

Tobar, N., Rocha, G. Z., Santos, A., Guadagnini, D., Assalin, H. B., Camargo, J. A., Gonçalves, A. E. S. S., Pallis, F. R., Oliveira, A. G., Rocco, S. A., Neto, R. M., de Sousa, I. L., Alborghetti, M. R., Sforça, M. L., Rodrigues, P. B., Ludwig, R. G., Vanzela, E. C., Brunetto, S. Q., Boer, P. A., …, & Saad, M. J. A. (2023). Metformin acts in the gut and induces gut-liver crosstalk. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2211933120

Vancouver

Tobar N, Rocha GZ, Santos A, Guadagnini D, Assalin HB, Camargo JA, et al. Metformin acts in the gut and induces gut-liver crosstalk. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2211933120

BibTeX
@article{Tobar2023,
  author = {Tobar, Natália and Rocha, Guilherme Z and Santos, Andrey and Guadagnini, Dioze and Assalin, Heloísa B and Camargo, Juliana A and Gonçalves, Any E S S and Pallis, Flavia R and Oliveira, Alexandre G and Rocco, Silvana A and Neto, Raphael M and de Sousa, Irene Layane and Alborghetti, Marcos R and Sforça, Maurício L and Rodrigues, Patrícia B and Ludwig, Raissa G and Vanzela, Emerielle C and Brunetto, Sergio Q and Boer, Patrícia A and Gontijo, José A R and Geloneze, Bruno and Carvalho, Carla R O and Prada, Patricia O and Folli, Franco and Curi, Rui and Mori, Marcelo A and Vinolo, Marco A R and Ramos, Celso D and Franchini, Kleber G and Tormena, Claudio F and Saad, Mario J A},
  title = {Metformin acts in the gut and induces gut-liver crosstalk},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2211933120}
}
Kostenlos starten →